HISTOGENICS CORP's ticker is HSGX and the CUSIP is 43358V109. A total of 19 filers reported holding HISTOGENICS CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $0 | -100.0% | 500 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | -66.7% | 500 | -61.5% | 0.00% | – |
| Q3 2017 | $3,000 | +50.0% | 1,300 | 0.0% | 0.00% | – |
| Q2 2017 | $2,000 | 0.0% | 1,300 | 0.0% | 0.00% | – |
| Q1 2017 | $2,000 | +100.0% | 1,300 | +62.5% | 0.00% | – |
| Q4 2016 | $1,000 | -75.0% | 800 | -33.3% | 0.00% | – |
| Q3 2016 | $4,000 | -20.0% | 1,200 | -54.7% | 0.00% | – |
| Q2 2016 | $5,000 | -16.7% | 2,650 | -3.6% | 0.00% | – |
| Q1 2016 | $6,000 | -45.5% | 2,750 | -15.4% | 0.00% | – |
| Q4 2015 | $11,000 | -15.4% | 3,250 | 0.0% | 0.00% | – |
| Q3 2015 | $13,000 | -23.5% | 3,250 | +20.4% | 0.00% | – |
| Q2 2015 | $17,000 | -46.9% | 2,700 | -15.6% | 0.00% | – |
| Q1 2015 | $32,000 | +300.0% | 3,200 | +374.1% | 0.00% | – |
| Q4 2014 | $8,000 | – | 675 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Management VIII, L.L.C. | 2,077,040 | $3,469,000 | 1.95% |
| Abingworth LLP | 888,889 | $1,440,000 | 1.20% |
| ARMISTICE CAPITAL, LLC | 1,264,000 | $2,111,000 | 0.50% |
| Third Security, LLC | 2,690,570 | $4,493,000 | 0.24% |
| Perceptive Advisors | 1,777,777 | $2,968,000 | 0.21% |
| CARL DOMINO INC | 87,000 | $145,000 | 0.16% |
| SABBY MANAGEMENT, LLC | 944,891 | $1,578,000 | 0.09% |
| Palo Alto Investors LP | 302,922 | $506,000 | 0.03% |
| PURA VIDA INVESTMENTS, LLC | 13,526 | $23,000 | 0.01% |
| Virtu KCG Holdings LLC | 14,764 | $25,000 | 0.00% |